三个皮匠报告
最新
报告分类 研搜
BETA
政策库
自研报告
new
入驻
搜索
您的当前位置：首页 > 行业数据 > RC18比贝利尤单抗降低SLE患者IgM、IgG及IgA水平的效果更好（非头对头结果），时间更早
图片属性
图片格式：PNG 图片大小：124KB 图片尺寸：2303*964
同报告图片
 / 4
RC18比贝利尤单抗降低SLE患者IgM、IgG及IgA水平的效果更好（非头对头结果），时间更早_第1页
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
RC18比贝利尤单抗降低SLE患者IgM、IgG及IgA水平的效果更好（非头对头结果），时间更早_第2页
RC18比贝利尤单抗降低SLE患者IgM、IgG及IgA水平的效果更好（非头对头结果），时间更早_第3页
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
RC18比贝利尤单抗降低SLE患者IgM、IgG及IgA水平的效果更好（非头对头结果），时间更早_第4页
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
RC18比贝利尤单抗降低SLE患者IgM、IgG及IgA水平的效果更好（非头对头结果），时间更早_第5页
所属报告： 荣昌生物-第四次全球制药工业变革浪潮的中国力量-220918（100页）.pdf
打包全文图表

相关数据

最新数据
全行业研究报告分享下载平台
  • 0731-84720580
  • 商务合作：really158d
关于我们
更多
关于我们
三个皮匠报告微信公众号
三个皮匠报告微信小程序
扫码咨询网站充值下载问题
copyright@2008-2013 长沙景略智创信息技术有限公司版权所有        网站备案/许可证号：湘B2-20190120 | 工信部备案号：湘ICP备17000430号-2 | 公安备案号：湘公网安备43010402001071号
客服
商务合作
小程序
服务号
折叠